Tiedemann Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$95.1K Hold
2023
Q2
$78K Buy
2023
Q1
$68.3K Buy
2022
Q4
$70.6K Buy
2022
Q3
$377K Hold
2022
Q2
$194K Buy
2021
Q3
Sell
2021
Q2
$1.78M Hold
2021
Q1
$1.96M Hold
2020
Q4
$1.78M Sell
2020
Q3
$10.2M Sell
2020
Q2
$12.6M Hold
2020
Q1
$9.64M Hold
2019
Q4
$11M Buy